Table 4.
N=106 | Male N=44a |
Female N=62a |
||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
SF-36 PCS score 6 months post-HCT | ||||||
≤40 (referent) | 1 | 1 | ||||
>40 | 2.72 | 1.10, 6.70 | 0.03 | 2.80 | 1.09, 7.18 | 0.03 |
Age at transplant (years) | ||||||
<35 (referent) | 1 | 1 | ||||
35–49 | 0.48 | 0.19, 1.13 | 0.09 | 1.36 | 0.52, 3.58 | 0.53 |
50+ | 0.87 | 0.26, 2.82 | 0.82 | 0.52 | 0.15, 1.78 | 0.30 |
Total body irradiation | ||||||
No (referent) | 1 | 1 | ||||
Yes | 1.34 | 0.53, 3.38 | 0.53 | 0.53 | 0.22, 1.28 | 0.16 |
Chronic graft-vs-host disease (GVHD)b | ||||||
No (referent) | 1 | 1 | ||||
Yes | 0.58 | 0.24, 1.37 | 0.22 | 0.92 | 0.41, 2.06 | 0.84 |
Sample is comprised of the patients who had not returned to work by 6 months post-HCT and had not died or relapsed by 6 months
Chronic GVHD included as a time dependent covariate by onset of GVHD